AU2994599A - Active immunization against angiogenesis-associated antigens - Google Patents

Active immunization against angiogenesis-associated antigens

Info

Publication number
AU2994599A
AU2994599A AU29945/99A AU2994599A AU2994599A AU 2994599 A AU2994599 A AU 2994599A AU 29945/99 A AU29945/99 A AU 29945/99A AU 2994599 A AU2994599 A AU 2994599A AU 2994599 A AU2994599 A AU 2994599A
Authority
AU
Australia
Prior art keywords
associated antigens
immunization against
active immunization
against angiogenesis
angiogenesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29945/99A
Other languages
English (en)
Inventor
Soldano Ferrone
Daniel J. Hicklin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York Medical College
ImClone LLC
Original Assignee
New York Medical College
ImClone Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Medical College, ImClone Systems Inc filed Critical New York Medical College
Publication of AU2994599A publication Critical patent/AU2994599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464454—Enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU29945/99A 1998-03-06 1999-03-08 Active immunization against angiogenesis-associated antigens Abandoned AU2994599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3672498A 1998-03-06 1998-03-06
US09036724 1998-03-06
PCT/US1999/005164 WO1999045018A1 (fr) 1998-03-06 1999-03-08 Immunisation active contre les antigenes associes a l'angiogenese

Publications (1)

Publication Number Publication Date
AU2994599A true AU2994599A (en) 1999-09-20

Family

ID=21890263

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29945/99A Abandoned AU2994599A (en) 1998-03-06 1999-03-08 Active immunization against angiogenesis-associated antigens

Country Status (4)

Country Link
EP (1) EP1032583A4 (fr)
AU (1) AU2994599A (fr)
CA (1) CA2310252A1 (fr)
WO (1) WO1999045018A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1156824A2 (fr) * 1999-03-11 2001-11-28 EntreMed, Inc. Compositions et techniques permettant de traiter le cancer et les troubles hyperproliferatifs
FR2796073B1 (fr) * 1999-07-07 2003-08-29 Centre Nat Rech Scient Anticorps anti-idiotypiques des facteurs de croissance des fibroblastes et leur utilisation comme medicaments
US7087592B1 (en) 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
US7094410B2 (en) * 2002-03-02 2006-08-22 The Scripps Research Institute DNA vaccine against proliferating endothelial cells and methods of use thereof
CU23178A1 (es) * 2002-04-15 2006-09-22 Ct Ingenieria Genetica Biotech INMUNOTERAPIA ACTIVA ANTIANGIOGéNICA
JP2006502111A (ja) * 2002-07-05 2006-01-19 デューク・ユニバーシティ 血管免疫治療
EP2001482B1 (fr) 2006-03-20 2016-08-24 CASI Pharmaceuticals, Inc. 2-méthoxyestradiol présentant une activité anti-arthritique pouvant modifier l'évolution de la maladie
WO2008006187A2 (fr) * 2006-07-12 2008-01-17 Legeev, Yury V. Complexes de protéines pour la prévention et le traitement de maladies associées à des troubles de l'angiogenèse
CU24637B1 (es) 2019-12-24 2022-12-12 Ct Ingenieria Genetica Biotecnologia Polipéptidos que comprenden mutantes del vegf-a humano con re-arreglos de puentes disulfuro y composiciones que los contienen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006916B1 (fr) * 1977-09-28 1981-07-08 National Research Development Corporation Préparations immunoligiques contenant MHC antigens et leur production
US4778752A (en) * 1983-10-11 1988-10-18 Scripps Clinic And Research Foundation Receptors specific for hapten-modified self proteins
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
JPH04506662A (ja) * 1989-07-14 1992-11-19 アメリカン・サイアナミド・カンパニー 接合体ワクチンのためのサイトカイニンおよびホルモンのキヤリヤー
EP0438803B1 (fr) * 1990-01-26 1997-03-12 Immunomedics, Inc. Vaccins contre le cancer et les maladies infectieuses
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
WO1993022343A1 (fr) * 1992-05-01 1993-11-11 The Rockfeller University Systeme antigenique a plusieurs peptides possedant des proprietes d'adjuvant, vaccins prepares a partir dudit systeme
JPH08502954A (ja) * 1992-08-31 1996-04-02 ジェナー テクノロジーズ 抗−イディオタイプ抗体を用いた抗腫瘍ｔ細胞応答の刺激
FR2742662B1 (fr) * 1995-12-21 1998-01-23 Centre Nat Rech Scient Anticorps anti-idiotypiques du facteur de croissance endotheliale vasculaire et leur utilisation comme medicaments
CA2240834C (fr) * 1995-12-22 2013-12-03 Immunomedics, Inc. Utilisation d'immunoconjugues pour accroitre l'efficacite des vaccins multietapes stimulant les reactions immunitaires en cascade

Also Published As

Publication number Publication date
CA2310252A1 (fr) 1999-09-10
WO1999045018A1 (fr) 1999-09-10
EP1032583A4 (fr) 2005-02-02
EP1032583A1 (fr) 2000-09-06

Similar Documents

Publication Publication Date Title
ZA991307B (en) Antibodies against human CD40.
AU1290001A (en) Antibodies
AU7912100A (en) Pharmaceutical composition comprising an antigen
AU1462300A (en) Human pan-hcv human monoclonal antibodies
ZA99452B (en) Antibodies against human IL-12.
AU1951201A (en) Peptide antigens
AU4935000A (en) Antibodies
AU2001256325A1 (en) Human and humanized fap-alpha-specific antibodies
AU3159499A (en) Antigen preparation and use
AU5441000A (en) Human monoclonal antibody
AU2994599A (en) Active immunization against angiogenesis-associated antigens
AU2977500A (en) Advanced antigen presentation platform
AU6278300A (en) Tumor-associated antigen (r11)
AU6212900A (en) Single-lens stereoscopic light-valves and apparatuses
AU3283500A (en) Tumor-associated antigen
AU2001235834A1 (en) Closure device for the diffusion of aroma
AU7572198A (en) Tumor-associated antigen
AU6318699A (en) Seat device
AU2001261534A1 (en) The meca-79 antigen and related methods
AU4021800A (en) Human sperm surface antigens
AU2001245552A1 (en) Transcutaneous immunization for large particulate antigens
AU7788600A (en) Colon-tumour-associated antigens
AU4553100A (en) Tumour-associated antigen
AU6227800A (en) Recombinant antibody directed against human sperm antigen
GB9915419D0 (en) Antigens